CGON — CG Oncology, Inc. Common stock · rev $4.0M

CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.

Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.

Use this CGON page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CGON quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CGON SEC filings page. Lician reads the product cache first so this HTML stays unique to CG Oncology, Inc. Common stock even when a live quote feed is slow.